services banner

work with AvanceAvance Shop




rival software


Join our Linked-In discussion group
Join our discussion group "Valuation in Life Sciences"

Categories > Reports

2009-01
Success Rates in Biotech - Going The Wrong Way
The report "Success Rates in Biotech - Going The Wrong Way" summarizes our review of 211 public biotech companies comprising over 1,500 drug development projects

Content and Figures

Price:

Items 1 to 1 of 1

 

Shopping Cart

Checkout

 

 

 

 

 

 

 



Home | About Avance | Services | ri:val | Publications | Book | Contact | Disclaimer-Terms